Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

196 ARTÍCULOS , VIENDO DEL 106 AL 120

Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer biomarkers

Arenaza-Urquijo EM, Salvadó G, Operto G, Minguillón C, Sánchez-Benavides G, Crous-Bou M, Grau-Rivera O, Sala-Vila A, Falcón C, Suárez-Calvet M, Zetterberg H, Blennow K, Gispert JD, Molinuevo JL; ALFA Study.

Neurology. 2020 Oct 13;95(15):e2065-e2074. doi: 10.1212/WNL.0000000000010527. Epub 2020 Jul 31.

Disturbances in brain energy metabolism in insulin resistance and diabetes and Alzheimer's disease - Learnings from brain imaging biomarkers

Heurling K, Johansson E, Leuzy A.

Int Rev Neurobiol. 2020;154:111-130. doi: 10.1016/bs.irn.2020.02.011. Epub 2020 Jul 11.

Tracking the potential involvement of metabolic disease in Alzheimer's disease-Biomarkers and beyond

Luchsinger JA, Zetterberg H.

Int Rev Neurobiol. 2020;154:51-77. doi: 10.1016/bs.irn.2020.03.014. Epub 2020 Jul 10.

Visuospatial Memory Alteration in Alzheimer's Disease

Lin S.

Neurosci Bull. 2020 Aug;36(8):829-830. doi: 10.1007/s12264-020-00560-0. Epub 2020 Aug 2.

Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers

Koychev I, Hofer M, Friedman N.

J Nucl Med. 2020 Oct;61(10):1413-1418. doi: 10.2967/jnumed.119.230458. Epub 2020 Aug 6.

Comparing progression biomarkers in clinical trials of early Alzheimer's disease

Cullen NC, Zetterberg H, Insel PS, Olsson B, Andreasson U; Alzheimer’s Disease Neuroimaging Initiative; Blennow K, Hansson O, Mattsson-Carlgren N.

Ann Clin Transl Neurol. 2020 Sep;7(9):1661-1673. doi: 10.1002/acn3.51158. Epub 2020 Aug 11.

Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study

Ma YH, Wu JH, Xu W, Shen XN, Wang HF, Hou XH, Cao XP, Bi YL, Dong Q, Feng L, Tan L, Yu JT.

J Alzheimers Dis. 2020;77(1):411-421. doi: 10.3233/JAD-200410.

Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease

Bergland AK, Proitsi P, Kirsebom BE, Soennesyn H, Hye A, Larsen AI, Xu J, Legido-Quigley C, Rajendran L, Fladby T, Aarsland D.

J Alzheimers Dis. 2020;77(3):1117-1127. doi: 10.3233/JAD-200441.

Erythrocytes as markers of oxidative stress related pathologies

Massaccesi L, Galliera E, Corsi Romanelli MM.

Mech Ageing Dev. 2020 Oct;191:111333. doi: 10.1016/j.mad.2020.111333. Epub 2020 Aug 16.

Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study

Saddiki H, Fayosse A, Cognat E, Sabia S, Engelborghs S, Wallon D, Alexopoulos P, Blennow K, Zetterberg H, Parnetti L, Zerr I, Hermann P, Gabelle A, Boada M, Orellana A, de Rojas I, Lilamand M, Bjerke M, Van Broeckhoven C, Farotti L, Salvadori N, Diehl-Schmid J, Grimmer T, Hourregue C, Dugravot A, Nicolas G, Laplanche JL, Lehmann S, Bouaziz-Amar E; Alzheimer’s Disease Neuroimaging Initiative; Hugon J, Tzourio C, Singh-Manoux A, Paquet C, Dumurgier J.

PLoS Med. 2020 Aug 20;17(8):e1003289. doi: 10.1371/journal.pmed.1003289. eCollection 2020 Aug.

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease

Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, Najda A, Bin-Jumah MN, El-Seedi HR, Abdel-Daim MM.

Int J Mol Sci. 2020 Aug 14;21(16):5858. doi: 10.3390/ijms21165858.

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

Shi L, Winchester LM, Liu BY, Killick R, Ribe EM, Westwood S, Baird AL, Buckley NJ, Hong S, Dobricic V, Kilpert F, Franke A, Kiddle S, Sattlecker M, Dobson R, Cuadrado A, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Ten Kate M, Scheltens P, Vandenberghe R, Gabel S, Meersmans K, Engelborghs S, De Roeck EE, Sleegers K, Frisoni GB, Blin O, Richardson JC, Bordet R, Molinuevo JL, Rami L, Wallin A, Kettunen P, Tsolaki M, Verhey F, Lleó A, Alcolea D, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Johannsen P, Teunissen CE, Freund-Levi Y, Frölich L, Legido-Quigley C, Barkhof F, Blennow K, Rasmussen KL, Nordestgaard BG, Frikke-Schmidt R, Nielsen SF, Soininen H, Vellas B, Kloszewska I, Mecocci P, Zetterberg H, Morgan BP, Streffer J, Visser PJ, Bertram L, Nevado-Holgado AJ, Lovestone S.

J Alzheimers Dis. 2020;77(3):1353-1368. doi: 10.3233/JAD-200208.

Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets

Lakshmi S, Essa MM, Hartman RE, Guillemin GJ, Sivan S, Elumalai P.

Neurochem Res. 2020 Nov;45(11):2553-2559. doi: 10.1007/s11064-020-03111-1. Epub 2020 Aug 25.

Extending Alzheimer disease biomarker studies into the Hispanic community

Bennett DA, Knopman DS.

Neurology. 2020 Oct 13;95(15):665-666. doi: 10.1212/WNL.0000000000010714. Epub 2020 Aug 26.

Sleep spindle abnormalities related to Alzheimer's disease: a systematic mini-review

Weng YY, Lei X, Yu J.

Sleep Med. 2020 Nov;75:37-44. doi: 10.1016/j.sleep.2020.07.044. Epub 2020 Aug 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias